美能和咪唑斯汀治疗慢性荨麻疹疗效观察被引量：1

导出

摘要目的探讨美能(复方甘草酸苷)联合咪唑斯汀治疗慢性荨麻疹临床疗效和安全性。方法随机分为观察组150例和对照组120例,观察组采用复方甘草酸苷联合咪唑斯汀治疗,第1个月服美能(复方甘草酸苷)片50mg,3次/d,咪唑斯汀片10mg1,次/d口服;第2个月给予美能(复方甘草酸苷)片、咪唑斯汀片隔日交替服用;对照组第1个月服咪唑斯汀片10mg,1次/d,第2个月咪唑斯汀片隔日服用。两组均停药2个月后判断疗效。结果观察组有效率(84.67%)显著高于对照组(71.67%)(χ2=6.007,P<0.05),两组均未发现明显不良反应。结论复方甘草酸酐联合咪唑斯汀治疗慢性荨麻疹安全性高,疗效好。

作者庞利涛

机构地区郑州市第三人民医院皮肤性病科

出处《医药论坛杂志》 2010年第24期135-136,共2页 Journal of Medical Forum

关键词慢性荨麻疹复方甘草酸苷咪唑斯汀

分类号 R758.24 [医药卫生—皮肤病学与性病学]

引文网络
相关文献

参考文献4

1王侠生,廖康煌.杨国亮皮肤病学[M].上海科学技术文献出版社,2006:407.
2郝飞.甘草酸国外研究进展[J].中国药房,2001,12(8):500-501. 被引量：107
3赵晓芳,王国安,杜秋燕.地氯雷他定治疗慢性荨麻疹[J].医药论坛杂志,2005,26(14):75-75. 被引量：2
4Salmun LM. Antihistamines in late - phase clinical de- velopment for allergic disease [ J ]. Expert Opin Investig Drugs, 2002,11 ( 2 ) : 259-73.

二级参考文献12

1[1]Takeda S,Ishthara K, Wakui Y, et al. Bioavailability study ofglycyrrhetic acid after oral administration of glycyrrhizin in rats;relevance to the intestinal bacterial hydrolysis[J].J PharmPharmacol,1996, 48(9):902.
2[2]Van Rossum TG, Vulto AG, De Man RA, et al. Review article:glycyrrhizinas a potential treatment for chron-ic hepatitis C[J].Aliment Pharmacol Ther, 1998, 12(2):199.
3[3]Van Rossum TG, Vulto AG, Hop WC, et al.Intraveno-us glycyrrhizin for the treatment of chronic hepatitis C:a double－blind, randomized, placebo controlled pha-se I/II trial[J]. J Gastroenterol Hepatol,1999, 14(11):1 093.
4[4]Yamamura Y, Kotaki H, Tanaka N, et al. The pharmaco-kinetics of glycyrrhizin and its restorative effect on he-patic function in patients with chronic hepatitis and in chronicallycarbon-tetrachloride-intoxicated rats[J].Biopharm Drug Dispos, 1997, 18(8):717.
5[5]Yamamura Y, Santa T, Kotaki H, et al. Administrationroute dependency of absorption of glycyrrhizin in rat-
6[6]s:intraperitoneal administration dramatically enhancedbioavailability[J]. Biol Pharm Bull, 1995,18(2):337.
7[7]Okamoto T, Tanaka N, Vulto AG, et al. The protectiveeffect of glycyrrhizin on anti-fas antibody-inducedhepatitis in mice[J]. Eur J Pharmacol, 2000, 387(2):229.
8[8]Okamoto T, Kanda T, Vulto AG, et al. Glycyrrhizin protects mice fromconcanavalin A-induced hepatitiswithout affecting cytokine expression[J]. Int J Mol M-ecl, 1999, 4(2):149.
9[9]Tsabota A. Corrbinecl ursodeoxycholic acid and glycyrrhizin therapy forchronic hepatitis C virus infection:a randomized controlled trial in 170patients[J].Eur J Gastroenterd Hepatol, 1999, 11(10):1 077.
10[10]Shiota G, Harada K, Ishida M, et al. Inhibition of hepatocellularcarcinoma by glycyrrhizin in diethylnitrosa-mine-treated mice[J]. Carcinogenesis, 1999,20(1):59.